Jiangsu Jitai Peptide Technology Co., Ltd. has registered capital of 10 million RMB. Its business scope includes production, research and development, sales of polypeptide products, research and development, consultation, service and transfer of biotechnology. The project invested 150 million yuan in high-tech enterprise accelerator plant of Binhai Pharmaceutical Industrial Park. New production lines of freeze-dried powder injection and injection are dedicated to building the whole industry chain of polypeptide products in the coastal area. Headquartered in Shanghai, with a construction area of 35,000 square meters and more than 1,000 employees, the company is a large-scale manufacturer of amino acid, polypeptide and antibody products led by a team of doctoral experts at home and abroad. The company has five production bases and two research and development centers at home and abroad. Powerful comprehensive strength, 20 years of rich quality management experience, huge scale effect, to provide customers around the world with high quality, low price, high-tech content of all kinds of polypeptide products.
